| Ytd | 18.59% | |
| 1y | 22.18% |
| Open | 179.76 | Prev Close | 181.38 | Low | 179.42 | High | 182.62 | Mkt Cap | 49.29B |
| Vol | 6.24M | Avg Vol | 2.08M | EPS | 5.77 | P/E | 31.36 | Forward P/E | 13.61 |
| Beta | 0.21 | Short Ratio | 5.76 | Inst. Own | 99.72% | Dividend | 4.20 | Div Yield | 2.32 |
| Ex Div Date | 09-09 | Earning | 11-05 | 50-d Avg | 174.79 | 200-d Avg | 161.12 | 1yr Est | 195.67 |
Dividend Kings have a 50+ year track record of increasing dividends, showcasing resilience through e
Corient Private Wealth LP lessened its position in shares of Becton, Dickinson and Company (NYSE: BD
BD expands U.S. pharmacy automation with Vmax 160 at Fairview to handle complex specialty and refrig
First-of-its-kind U.S. deployment of BD Vmax 160 expands pharmacy automation beyond traditional disp
B of A Securities analyst Travis Steed maintains Becton Dickinson (NYSE:BDX) with a Neutral and r
FDA alerts Becton Dickinson customers to remove recalled Huons sodium chloride ampules from convenie
FDA alerts providers as Medline corrects convenience kits with recalled BD applicators due to steril
RBC Capital analyst Kendall Au maintains Becton Dickinson (NYSE:BDX) with a Sector Perform and ra
Enrollment completed in the first large-scale randomized study evaluating Phasix™ Mesh for incisiona
Citigroup analyst Joanna Wiensch maintains Becton Dickinson (NYSE:BDX) with a Buy and raises the
RBC Capital analyst Kendall Au maintains Becton Dickinson (NYSE:BDX) with a Sector Perform and ra
Piper Sandler analyst Jason Bednar maintains Becton Dickinson (NYSE:BDX) with a Neutral and raise
Wells Fargo analyst Lawrence Biegelsen maintains Becton Dickinson (NYSE:BDX) with a Equal-Weight
Becton Dickinson raises 2026 adjusted EPS guidance after reporting Q3 revenue growth across core med
Becton, Dickinson (NYSE:BDX) reported quarterly earnings of $3.23 per share which beat the analyst c
Becton Dickinson (NYSE:BDX) raises FY2026 Adj EPS guidance from $12.52-$12.72 to $12.62-$12.72 vs $1
TD Cowen analyst Joshua Jennings maintains Becton Dickinson (NYSE:BDX) with a Hold and raises the
UBS analyst Patrick Wood initiates coverage on Becton Dickinson (NYSE:BDX) with a Buy rating and
Evercore ISI Group analyst Vijay Kumar maintains Becton Dickinson (NYSE:BDX) with a Outperform an
The contract was awarded following a review by hospital experts serving on Vizient's client-led
Barclays analyst Matt Miksic maintains Becton Dickinson (NYSE:BDX) with a Overweight and raises t
Wells Fargo analyst Lawrence Biegelsen maintains Becton Dickinson (NYSE:BDX) with a Equal-Weight
Becton Dickinson (NYSE: BDX) tops Q2 estimates with $4.71B revenue and raises 2026 earnings outlook.
Becton Dickinson (NYSE:BDX) raises FY2026 Adj EPS guidance from $12.35-$12.65 to $12.52-$12.72 vs $1
Becton, Dickinson (NYSE:BDX) reported quarterly earnings of $2.90 per share which beat the analyst c
By integrating the BD Pyxis™ Pro and BD Alaris™ platforms, Wellstar Health System is giving clinicia
TD Cowen analyst Joshua Jennings maintains Becton Dickinson (NYSE:BDX) with a Hold and lowers the
Piper Sandler analyst Jason Bednar maintains Becton Dickinson (NYSE:BDX) with a Neutral and lower
Goldman Sachs analyst David Roman reinstates Becton Dickinson (NYSE:BDX) with a Neutral and annou
CE Marking and ARCH clinical trial data position the Liverty™ TIPS Stent Graft to expand treatment o
Argus Research analyst David Toung maintains Becton Dickinson (NYSE:BDX) with a Buy and lowers th
This latest addition to the Surgiphor portfolio empowers clinicians to mechanically loosen and remov
BD (Becton, Dickinson and Company) (NYSE:BDX) (the "Company" or "BD"), a leading glo
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today an
Barclays analyst Matt Miksic reinstates Becton Dickinson (NYSE:BDX) with a Overweight and announc
Jefferies analyst Matthew Taylor maintains Becton Dickinson (NYSE:BDX) with a Buy and lowers the
Becton Dickinson (BDX) reported Q1 2026 earnings above consensus and provided guidance for the year.
U.S. stocks are little changed on Tuesday, but the Dow Jones Industrial Average is stealing the spot
BD (Becton, Dickinson and Company) (NYSE:BDX) (the "Company" or "BD"), a leading glo
RBC Capital analyst Shagun Singh maintains Becton Dickinson (NYSE:BDX) with a Sector Perform and
Citigroup analyst Joanna Wiensch maintains Becton Dickinson (NYSE:BDX) with a Buy and lowers the
Piper Sandler analyst Jason Bednar reiterates Becton Dickinson (NYSE:BDX) with a Neutral and lowe
Wells Fargo analyst Lawrence Biegelsen maintains Becton Dickinson (NYSE:BDX) with a Equal-Weight
The CNN Money Fear and Greed index improved, with the market moving to Neutral zone. Dow and Nasdaq